Search hospitals > Nevada > Las Vegas
Comprehensive Cancer Centers of Nevada
Claim this profileLas Vegas, Nevada 89148
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Prostate Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Tumors
464 reported clinical trials
16 medical researchers
Summary
Comprehensive Cancer Centers of Nevada is a medical facility located in Las Vegas, Nevada. This center is recognized for care of Cancer, Breast Cancer, Prostate Cancer, Non-Small Cell Lung Cancer, Tumors and other specialties. Comprehensive Cancer Centers of Nevada is involved with conducting 464 clinical trials across 457 conditions. There are 16 research doctors associated with this hospital, such as John A. Ellerton, Alan K. Ikeda, Fadi Braiteh, MD, and Nicholas Vogelzang, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
John A. EllertonOptumCare Cancer Care at Fort Apache4 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
148 reported clinical trials
226 drugs studied
Alan K. IkedaAlliance for Childhood Diseases/Cure 4 the Kids Foundation7 years of reported clinical research
Expert in Tumors
Expert in Leukemia
52 reported clinical trials
109 drugs studied
Fadi Braiteh, MDComprehensive Cancer Centers of Nevada4 years of reported clinical research
Studies Solid Tumors
Studies Non-Small Cell Lung Cancer
19 reported clinical trials
34 drugs studied
Nicholas Vogelzang, MDComprehensive Cancer Centers of Nevada5 years of reported clinical research
Studies Prostate Cancer
Studies Solid Tumors
12 reported clinical trials
27 drugs studied
Clinical Trials running at Comprehensive Cancer Centers of Nevada
Breast Cancer
Prostate Cancer
Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Tumors
Bladder Cancer
Solid Tumors
Squamous Cell Carcinoma
Gastric Cancer
Sacituzumab Govitecan + Pembrolizumab
for Triple Negative Breast Cancer
The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after surgery and pre-surgical treatment.
Recruiting2 awards Phase 36 criteria
ARV-471
for Breast Cancer
This trial tests a new oral medicine, ARV-471, against an existing injectable treatment, fulvestrant, in people with advanced breast cancer that has spread. Both medicines aim to slow cancer growth by targeting estrogen receptors. ARV-471 is developed as an oral alternative to fulvestrant.
Recruiting2 awards Phase 35 criteria
Giredestrant + Hormone Therapy
for Early-Stage Breast Cancer
This trial is testing giredestrant, a medication given after initial treatment to prevent breast cancer from returning. It focuses on patients with a specific type of early-stage breast cancer that is hormone-driven and at higher risk of recurrence. Giredestrant works by blocking the hormone estrogen from helping cancer cells grow. Giredestrant has shown promise in previous studies.
Recruiting2 awards Phase 311 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Comprehensive Cancer Centers of Nevada?
Comprehensive Cancer Centers of Nevada is a medical facility located in Las Vegas, Nevada. This center is recognized for care of Cancer, Breast Cancer, Prostate Cancer, Non-Small Cell Lung Cancer, Tumors and other specialties. Comprehensive Cancer Centers of Nevada is involved with conducting 464 clinical trials across 457 conditions. There are 16 research doctors associated with this hospital, such as John A. Ellerton, Alan K. Ikeda, Fadi Braiteh, MD, and Nicholas Vogelzang, MD.
Where is Comprehensive Cancer Centers of Nevada located?
The Comprehensive Cancer Centers of Nevada is located at 7445 Peak Dr., Las Vegas, NV 89128. For directions, from downtown Las Vegas, take I-15 N to US-95 N towards Henderson, exit 81A for Summerlin Pkwy W, continue on Lake Mead Blvd, then turn right onto Peak Dr. The hospital will be on your left.
Who should I call to ask about financial aid or insurance network?
For general health insurance inquiries in Nevada, contact the Office of the Consumer Health Advocate at 1-888-333-1597. For employer-provided insurance questions, reach out to the Nevada Division of Insurance at (888) 872-3234. Comprehensive Cancer Centers of Nevada offers financial counseling to assist with treatment costs and insurance matters; visit their Contact Us page for more information.
What insurance does Comprehensive Cancer Centers of Nevada accept?
The Comprehensive Cancer Centers of Nevada accept a wide range of insurance plans, including commercial insurance, Medicare, Medicare Part C, Medicaid in some cases, and certain U.S. Department of Veterans Affairs and TRICARE plans. For detailed information on coverage, it is recommended to contact an Oncology Information Specialist at the center.
What awards or recognition has Comprehensive Cancer Centers of Nevada received?
Comprehensive Cancer Centers of Nevada (CCCN) is recognized for its excellence in clinical care and research, having been designated as a Comprehensive Cancer Center by the National Cancer Institute (NCI). Its physicians were named Best Doctors by Healthcare Quarterly and Desert Companion in 2021. CCCN actively participates in over 170 clinical trials annually, contributing to the development of more than 100 FDA-approved cancer therapies.